Though the chance of developing brain cancer is quite rare, it is ranked as the tenth leading cause of death for both men and women.
Despite being one of the most common cancers amongst children, brain cancer is relatively rare amongst the…
The 2020 Give to Cure Cancer Year-End Appeal is now underway. It’s your last chance to make this year’s campaign the most successful ever.
We are proud to report...
The year of 2020 turns out to be an unprecedented time of new…
Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here.
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
In addition to surgery, radiation therapy and chemotherapy are…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19.
Glioblastoma,…
The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is…
W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s…
This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the…
March 16-17, 2018
Changsha, Hunan, People’s Republic of China
The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the founder and chief executive officer of the Asian Fund for Cancer Research (AFCR), to give a lecture at its annual meeting, SNOChina 2018, to…
The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the founder and chief executive officer of the Asian Fund for Cancer Research (AFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on…
NFCR President receives the inaugural award from Society for Neuro-Oncology of the Chinese Medical Doctor Association for her outstanding contribution to international cooperation in March 2017.
Dr. Jiang Tao, the Chairman of the Society for Neuro-Oncology of the Chinese Medical Doctor Association and the…